119 HR 2197 IH: No 340B Savings for Transgender Care Act U.S. House of Representatives 2025-03-18 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I119th CONGRESS1st SessionH. R. 2197IN THE HOUSE OF REPRESENTATIVESMarch 18, 2025Mr. Johnson of South Dakota (for himself, Mr. Austin Scott of Georgia, Mr. Crenshaw, Mr. Rulli, Mr. Ezell, Mrs. Bice, Mr. Moore of Alabama, and Mr. Rose) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo prevent 340B covered entities from using savings derived for sex reassignment surgeries, hormonal therapies, and for other purposes.

1.

Short title

This Act may be cited as the No 340B Savings for Transgender Care Act.

2.

Prohibition on use of 340b savings for services described for transgender individuals

(a)

Prohibition on use of 340B savings for services described

Section 340B(a)(4) of the Public Health Service Act (42 U.S.C. 256b(a)(5)) is amended by adding at the end the following:(E)

Prohibition on use of 340b savings for services described

A covered entity participating in the program under this section may not use any funds derived from the difference between the 340B ceiling price and the actual acquisition cost of covered outpatient drugs to pay for services described.(i)

Definitions

For purposes of this subsection—(I)

Covered entity

The term covered entities has the meaning given such term in section 340B(a)(4).(II)

Services described

The term services described means—(aa)sex reassignment surgeries furnished for the purpose of the gender alteration of a transgender individual; and(bb)hormone treatments furnished for the purpose of the gender alteration of a transgender individual..